PortfoliosLab logoPortfoliosLab logo
MDT vs. ABT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MDT vs. ABT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medtronic plc (MDT) and Abbott Laboratories (ABT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MDT achieves a -16.80% return, which is significantly higher than ABT's -29.10% return. Over the past 10 years, MDT has underperformed ABT with an annualized return of 2.15%, while ABT has yielded a comparatively higher 10.82% annualized return.


MDT

1D
-0.09%
1M
0.85%
YTD
-16.80%
6M
-17.61%
1Y
-5.27%
3Y*
-0.30%
5Y*
-5.95%
10Y*
2.15%

ABT

1D
-0.66%
1M
0.48%
YTD
-29.10%
6M
-29.05%
1Y
-32.61%
3Y*
-4.78%
5Y*
-2.74%
10Y*
10.82%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MDT vs. ABT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MDT
Medtronic plc
-16.80%24.05%0.28%9.58%-22.55%-9.79%5.70%27.34%15.18%15.90%
ABT
Abbott Laboratories
-29.10%12.87%4.81%2.26%-20.68%30.53%28.04%22.08%29.06%52.03%

Correlation

The correlation between MDT and ABT is 0.52, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.52

Correlation (3Y)
Calculated over the trailing 3-year period

0.57

Correlation (5Y)
Calculated over the trailing 5-year period

0.57

Correlation (10Y)
Calculated over the trailing 10-year period

0.57

Correlation (All Time)
Calculated using the full available price history since Apr 6, 1983

0.39

The correlation between MDT and ABT shifts across timeframes, from 0.39 (all time) to 0.57 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

MDT:

$102.11B

ABT:

$153.44B

EPS

MDT:

$3.73

ABT:

$3.59

PE Ratio

MDT:

21.27

ABT:

24.47

PEG Ratio

MDT:

11.05

ABT:

1.52

PS Ratio

MDT:

2.81

ABT:

3.40

PB Ratio

MDT:

2.06

ABT:

2.32

Total Revenue (TTM)

MDT:

$36.36B

ABT:

$45.13B

Gross Profit (TTM)

MDT:

$23.64B

ABT:

$25.45B

EBITDA (TTM)

MDT:

$9.72B

ABT:

$10.80B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MDT vs. ABT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MDT
MDT Risk / Return Rank: 3131
Overall Rank
MDT Sharpe Ratio Rank: 3232
Sharpe Ratio Rank
MDT Sortino Ratio Rank: 2626
Sortino Ratio Rank
MDT Omega Ratio Rank: 2626
Omega Ratio Rank
MDT Calmar Ratio Rank: 3636
Calmar Ratio Rank
MDT Martin Ratio Rank: 3434
Martin Ratio Rank

ABT
ABT Risk / Return Rank: 44
Overall Rank
ABT Sharpe Ratio Rank: 11
Sharpe Ratio Rank
ABT Sortino Ratio Rank: 44
Sortino Ratio Rank
ABT Omega Ratio Rank: 44
Omega Ratio Rank
ABT Calmar Ratio Rank: 99
Calmar Ratio Rank
ABT Martin Ratio Rank: 22
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MDT vs. ABT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Medtronic plc (MDT) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MDTABTDifference
Sharpe ratioReturn per unit of total volatility

+1.08

Sortino ratioReturn per unit of downside risk

+1.58

Omega ratioGain probability vs. loss probability

0.97

0.76

+0.21

Calmar ratioReturn relative to maximum drawdown

-0.18

-0.84

+0.66

Martin ratioReturn relative to average drawdown

-0.44

-1.77

+1.33

MDT vs. ABT - Sharpe Ratio Comparison

The current MDT Sharpe Ratio is -0.25, which is higher than the ABT Sharpe Ratio of -1.33. The chart below compares the historical Sharpe Ratios of MDT and ABT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MDT vs. ABT - Drawdown Comparison

The maximum MDT drawdown since its inception was -57.63%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for MDT and ABT.


Loading charts...

Drawdown Indicators


MDTABTDifference

Max Drawdown

Largest peak-to-trough decline

-57.63%

-45.66%

-11.97%

Max Drawdown (1Y)

Largest decline over 1 year

-28.90%

-38.99%

+10.09%

Max Drawdown (3Y)

Largest decline over 3 years

-28.90%

-39.64%

+10.74%

Max Drawdown (5Y)

Largest decline over 5 years

-45.10%

-39.64%

-5.46%

Max Drawdown (10Y)

Largest decline over 10 years

-45.10%

-39.64%

-5.46%

Current Drawdown

Current decline from peak

-32.02%

-35.79%

+3.77%

Average Drawdown

Average peak-to-trough decline

-16.55%

-10.85%

-5.70%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.96%

18.40%

-6.44%

Volatility

MDT vs. ABT - Volatility Comparison

Medtronic plc (MDT) has a higher volatility of 10.05% compared to Abbott Laboratories (ABT) at 7.23%. This indicates that MDT's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MDTABTDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.05%

7.23%

+2.82%

Volatility (6M)

Calculated over the trailing 6-month period

16.78%

19.44%

-2.66%

Volatility (1Y)

Calculated over the trailing 1-year period

21.39%

24.70%

-3.31%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.00%

22.10%

-0.10%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.29%

23.68%

-0.39%

Dividends

MDT vs. ABT - Dividend Comparison

MDT's dividend yield for the trailing twelve months is around 3.58%, more than ABT's 2.78% yield.


PositionTTM20252024202320222021202020192018201720162015
ABT
Abbott Laboratories
2.78%1.88%1.95%1.85%1.71%1.28%1.32%1.47%1.55%1.86%2.71%2.14%
MDT
Medtronic plc
3.58%2.95%3.49%3.34%3.44%2.39%1.95%1.87%2.15%2.24%2.34%1.88%

Financials

MDT vs. ABT - Financials Comparison

This section allows you to compare key financial metrics between Medtronic plc and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


7.00B8.00B9.00B10.00B11.00B12.00B20222023202420252026
9.81B
11.16B
(MDT) Total Revenue
(ABT) Total Revenue
Values in USD except per share items

MDT vs. ABT - Profitability Comparison

The chart below illustrates the profitability comparison between Medtronic plc and Abbott Laboratories over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%55.0%60.0%65.0%70.0%75.0%20222023202420252026
75.9%
56.3%
Portfolio components
MDT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medtronic plc reported a gross profit of 7.44B and revenue of 9.81B. Therefore, the gross margin over that period was 75.9%.

ABT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a gross profit of 6.28B and revenue of 11.16B. Therefore, the gross margin over that period was 56.3%.

MDT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medtronic plc reported an operating income of 1.56B and revenue of 9.81B, resulting in an operating margin of 16.0%.

ABT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported an operating income of 1.84B and revenue of 11.16B, resulting in an operating margin of 16.5%.

MDT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medtronic plc reported a net income of 1.24B and revenue of 9.81B, resulting in a net margin of 12.7%.

ABT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a net income of 1.08B and revenue of 11.16B, resulting in a net margin of 9.7%.


Frequently Asked Questions


MDT and ABT have a correlation of 0.52, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MDT has higher volatility (10.05%) compared to ABT (7.23%). In terms of maximum drawdown, MDT dropped -57.63% vs ABT's -45.66%.

MDT currently has the higher Sharpe Ratio (-0.25 vs -1.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MDT and ABT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer